Por favor, tente outra busca
Nome | Idade | Desde | Título |
---|---|---|---|
Michael J. Higgins | 59 | 2015 | Independent Chairman |
Teofilo David Raad | 51 | 2017 | President, CEO & Director |
Richard P. Batycky | 54 | 2019 | Independent Director |
Michael E. Wechsler | - | - | Member of Pulmazole Clinical Advisory Board |
Mario Castro | - | - | Member of Pulmazole Clinical Advisory Board |
Christopher H. Cabell | 53 | 2020 | Independent Director |
Todd Bazemore | 52 | 2020 | Independent Director |
Anand Varadan | 55 | 2021 | Independent Director |
Cendrine Godet | - | - | Member of Pulmazole Clinical Advisory Board |
David A. Stevens | - | - | Member of Pulmazole Clinical Advisory Board |
Wisla Wedzicha | - | - | Member of PUR1800 Clinical Advisory Board |
Stephen Silberstein | - | - | Chair of PUR3100 (DHE) Clinical Advisory Board |
Jonathan Corren | - | - | Member of Pulmazole Clinical Advisory Board |
Russell G. Clayton | 61 | - | Member of Pulmazole & PUR1800 Clinical Advisory Board |
Peter Wark | - | - | Member of Pulmazole Clinical Advisory Board |
Richard B. Moss | - | - | Member of Pulmazole Clinical Advisory Board |
David W. Denning | - | - | Member of Pulmazole Clinical Advisory Board |
Ritesh Agarwal | - | - | Member of Pulmazole Clinical Advisory Board |
Russell A. Settipane | - | - | Member of Pulmazole Clinical Advisory Board |
Peter J. Goadsby | - | - | Member of PUR3100 (DHE) Clinical Advisory Board |
Abraham J. Nagy | - | - | Member of PUR3100 (DHE) Clinical Advisory Board |
Stewart J. Tepper | - | - | Member of PUR3100 (DHE) Clinical Advisory Board |
Fernando Martinez | - | 2022 | Member of PUR1800 Clinical Advisory Board |
William J. Calhoun | - | - | Chair of PUR1900 & PUR1800 Clinical Advisory Board |
Tem certeza de que deseja bloquear %USER_NAME%?
Ao confirmar o bloqueio, você e %USER_NAME% não poderão ver o que cada um de vocês posta no Investing.com.
%USER_NAME% foi adicionado com êxito à sua Lista de bloqueios
Já que acabou de desbloquear esta pessoa, você deve aguardar 48 horas antes de bloqueá-la novamente.
Diga-nos o que achou desse comentário
Obrigado!
Seu comentário foi enviado aos moderadores para revisão